SCHEMBL12438393

SCHEMBL12438393

CCN(CC)CCNC(=O)c1cncc([123I])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMEM97 Q5BJF2 1/20 0.53
▸ SIGMAR1 Q99720 1/20 0.53
▸ ALDH1A1 P00352 4/20 0.52
▸ LMNA P02545 2/20 0.52
▸ SLC22A2 O15244 1/20 0.52
▸ SLC22A1 O15245 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ ACHE P22303 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ BLM P54132 2/20 0.51
▸ PMP22 Q01453 1/20 0.51
▸ NFKB1 P19838 1/20 0.49
▸ KCNH2 Q12809 1/20 0.49
▸ CA12 O43570 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ POLB P06746 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ ATM Q13315 2/20 0.48
▸ CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12513598 0.84 LMNA (0.54) TMEM97SIGMAR1ALDH1A1LMNASLC22A2
SCHEMBL1134991 0.84 PKM (0.63) ALDH1A1LMNASLC22A2SLC22A1TSHR
SCHEMBL12438399 0.83 ALDH1A1 (0.52) TMEM97SIGMAR1ALDH1A1LMNASLC22A2
SCHEMBL12438407 0.83 ALDH1A1 (0.52) TMEM97SIGMAR1ALDH1A1LMNASLC22A2
SCHEMBL1135013 0.83 LMNA (0.52) TMEM97SIGMAR1ALDH1A1LMNASLC22A2
SCHEMBL12438394 0.82 DRD2 (0.54) ALDH1A1CYP2C19POLBSMN1; SMN2ATM
SCHEMBL1135005 0.81 ALDH1A1 (0.50) TMEM97SIGMAR1ALDH1A1LMNASLC22A2
SCHEMBL12391541 0.78 ALDH1A1 (0.72) TMEM97SIGMAR1ALDH1A1LMNASLC22A2
SCHEMBL6553954 0.76 KMT2A (0.59) ALDH1A1LMNASLC22A2SLC22A1TSHR
Hydrochloric Acid SCHEMBL8010729 0.75 LMNA (0.58) ALDH1A1LMNASLC22A2SLC22A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110178396-A1 Nicotinamide Derivatives CRC FOR BIOMEDICAL IMAGING DEVELOPMENT LTD. (AU) 2011-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178396-A1 Nicotinamide Derivatives NAMPT, NNT, NNMT TMEM97 3153/4885SIGMAR1 3244/4885ALDH1A1 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback